HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 51 filers reported holding HARPOON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $30,632 | -27.9% | 43,144 | -24.4% | 0.00% | – |
Q1 2023 | $42,479 | +32.7% | 57,080 | +71.1% | 0.00% | – |
Q3 2022 | $32,000 | -13.5% | 33,361 | +73.6% | 0.00% | – |
Q2 2022 | $37,000 | -95.8% | 19,212 | -83.6% | 0.00% | -100.0% |
Q4 2021 | $887,000 | -72.4% | 117,442 | -71.1% | 0.00% | -71.4% |
Q3 2021 | $3,211,000 | +556.6% | 406,470 | +1311.4% | 0.01% | +250.0% |
Q3 2020 | $489,000 | +1.5% | 28,800 | -0.8% | 0.00% | 0.0% |
Q2 2020 | $482,000 | +3.4% | 29,022 | -27.9% | 0.00% | -50.0% |
Q1 2020 | $466,000 | -20.3% | 40,232 | +1.7% | 0.00% | +100.0% |
Q4 2019 | $585,000 | – | 39,551 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |